locametz
novartis europharm limited - gozetotide - radionuklide bildebehandling - diagnostiske radiopharmaceuticals - dette legemidlet er kun til diagnostisk bruk. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.
cozaar 2.5 mg/ ml
merck sharp & dohme b.v. - losartankalium - pulver og væske til mikstur, suspensjon - 2.5 mg/ ml
cozaar 12.5 mg
merck sharp & dohme b.v. - losartankalium - tablett, filmdrasjert - 12.5 mg
cozaar 50 mg
farmagon - losartankalium - tablett, filmdrasjert - 50 mg
cozaar 50 mg
farmagon - losartankalium - tablett, filmdrasjert - 50 mg
cozaar 100 mg
n.v. organon - kloosterstraat - losartankalium - tablett, filmdrasjert - 100 mg
cozaar 50 mg
n.v. organon - kloosterstraat - losartankalium - tablett, filmdrasjert - 50 mg
cozaar 100 mg
orifarm as - losartankalium - tablett, filmdrasjert - 100 mg
linatil 5 mg
gea farmaceutisk fabrik as - enalaprilmaleat - tablett - 5 mg
linatil 2.5 mg
gea farmaceutisk fabrik as - enalaprilmaleat - tablett - 2.5 mg